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Abstract Once believed an exceedingly rare disorder,
recent evidence suggests that low cerebrospinal ﬂuid (CSF)
pressure headache has to be considered an important cause
of new daily persistent headaches, particularly among
young and middle-aged individuals. Treatment of low CSF
pressure headache consists of non-invasive/conservative
measures and invasive measures with epidural blood patch
providing the cornerstone of the invasive measures. In the
present pilot study we therefore aimed to evaluate the
treatment efﬁcacy of epidural blood patch (EBP) in treat-
ment-refractory low-pressure headache. Our primary effect
parameter was total headache burden deﬁned as area under
the curve (AUC: intensity 9 duration) and as secondary
effect parameters we identiﬁed: intensity (VAS 0-10),
frequency (days per month), duration in hours (total hours/
month) and also medication days (days on medication/
month). In our primary effect parameter we found a sig-
niﬁcant reduction in AUC with more than 25% and this is
considered to be clinically relevant. We found also a sig-
niﬁcant and relevant reduction at -22% in intensity. A
trend towards reduction in duration was seen. We found no
statistically signiﬁcant reduction in frequency. An increase
in days with use of medication was found. Increased
awareness of low CSF pressure headache is emphasized
and a controlled larger randomized study is needed to
conﬁrm the results. However the present results, allows us
to conclude that EBP in treatment-refractory low CSF
pressure headache can be considered as a treatment option.
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Purpose
To evaluate the treatment efﬁcacy of epidural blood patch
(EBP) in treatment-refractory low CSF (cerebrospinal
ﬂuid) pressure headache.
Introduction
Although ﬁrst described in 1938 low CSF pressure head-
ache is still an under-diagnosed headache disorder. This
being partly due to unfamiliarity, and with the overlap with
other forms of headache, often leading to misdiagnosis,
incorrect treatment and leaving the patient with a persistent
severe headache [1]. Low CSF pressure headache has
signiﬁcant symptom-overlap with migraine, tension type
headache, post-infectious headache and most commonly
post-dural puncture headache [2]. Symptoms vary greatly
but the orthostatic headache, tinnitus, hypacusis, photo-
phobia and/or nausea indicating low CSF pressure are the
most frequently reported [4]. However, the associated
symptoms may vary ranging from classic neurological
symptoms to cognitive defects [3]. Diffuse pachymeningeal
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is the major ﬁnding of the classic syndrome. However,
the diagnosis maybe difﬁcult in long lasting cases as the
cardinal symptom, the orthostatic headache-feature, may
disappear over time and the diffuse meningeal enhance-
ment may be absent. Over time various terminologies has
been used to describe the syndrome:
• Spontaneous (or idiopathic) low CSF pressure headache
• Spontaneous (or primary) intracranial hypotension
• Low CSF volume headache
• Hypoliquorrhoeic headache
• Aliquorrhea
• CSF leak headache
• CSF hypovolemia
• CSF volume depletion.
The accepted etiology is leakage of cerebrospinal ﬂuid,
either spontaneously or as a result of minor/trivial trauma,
instrumentation of or near the structures surrounding the
spinal cord. The leak is usually located in the upper tho-
racic level or at the cervico-thoracic junction [3]. As a
result of this leakage, the brain sags providing traction on
bridging veins, pain-sensitive meningeal structures and the
cranial nerves, possibly explaining the associated auditory
and, at times visual symptoms. In accordance with the
Monroe–Kellie doctrine, secondary venodilation may
develop as a compensatory measure to the low CSF pres-
sure, adding a vascular component with venous dilatation
to the typical MR-presentation introduced as SEEPS
(subdural hygroma, enhancement, engorged veins, pituitary
hyperaemia, and sagging of the brain [3]). Once believed to
be an exceedingly rare disorder, recent evidence suggests
that low CSF pressure headache is not that rare and has to
be considered an important cause of new daily persistent
headaches, particularly among young and middle-aged
individuals [4]. This said few data are available regarding
the demography of low CSF pressure headache. A peak
incidence centered around 40 years of age has been
reported, the incidence is estimated to 5 per 100,000 and
women are overrepresented in a 2:1 ratio [3].
Treatment of low CSF pressure headache consists of
non-invasive/conservative strategies and/or invasive mea-
sures with epidural blood patch providing the cornerstone
of the invasive measures. Although no randomized clinical
trials are available to evaluate the effectiveness of the
various treatment protocols, initial treatment for most
patients consist of conservative measures. The most con-
servative measure, bed rest and time, is probably effective
in many patients [3]. Analgesics are often employed early
as part of the conservative treatment they do though pro-
vide little relief. Steroid-therapy is of anecdotal value [4].
Apart from EBP, other invasive measures are surgical
repair and epidural ﬁbrin glue, they are though, limited by
the fact that the epidural lesion has to be located which is
not always possible [3]. EBP is the mainstay in the treat-
ment of low CSF pressure headache, but no protocol has
yet been developed. Treatment protocols vary between
injection of 10–100 ml autologous blood and 1–6 EBPs,
placement in the Trendelenburg position, premedication,
etc. [5]. In the present pilot study we therefore aimed to
evaluate the treatment efﬁcacy of epidural blood patch
(EBP) in treatment-refractory low-pressure headache.
Methods
We followed 14 patients all diagnosed at the Danish
Headache Center (DHC), the national tertiary headache
center, with low CSF pressure headache and treated with
EBP. All the patients followed in this pilot study presented
themselves with an orthostatic component as part of their
symptoms although an overlap in symptoms was seen. At
the time of initial evaluation, and at the time of the EBP all
patients, except two, described signiﬁcant worsening of the
headache either when erect or when physically active.
All patients had been refractory to conservative non-
invasive management and were referred to DHC for further
evaluation. Before their ﬁrst visit all patients receive a
diagnostic headache diary and are told to record headache
characteristics, including type and amount of medication
used, prospectively for at least a 4-week period. They also
ﬁll out a questionnaire regarding status of health, impact on
work, family and social life and prior headache treatment.
A detailed headache history is obtained by means of a
standardized procedure at the initial consultation. The
history is supplemented by the diagnostic headache diary
and the general medical questionnaire. After a complete
general physical and neurological examination, all ﬁrst-
visit patients were classiﬁed according to ICHD-II by a
headache specialist.
The headache diaries of the 14 patients were reviewed
prior to treatment with EBP and a second review at least
12 months after treatment with EBP. Additional phone-
interviews were performed and data from the preliminary
and ﬁnal examination were extracted in case of missing
data. Our primary effect parameter was total headache
burden deﬁned as area under the curve (AUC: inten-
sity 9 duration) and as secondary effect parameters we
identiﬁed: intensity (VAS 0-10), frequency (days per
month), duration in hours (total hours/month) and also
medication days (days on medication/month).
All EBP, but two, were performed by the same senior
anesthesiologist (J.F.) according to a standardized proce-
dure after obtaining full informed consent. All EBPs were
performed under strict aseptic conditions in an operating
room. The EBPs were all placed at the lumbar level (L2/3,
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123L3/4, and L4/5). All EBP were performed with 18-G
Touhy needle, using a midline approach with the patients
lying on one side. Autologous blood (6–37 ml; mean
23.64 ml) was injected until patients complained of lumbar
pain. After the procedure the patients were placed supine in
bed for the next 24 h.
Results
In the period of 2005–2010 we intended to treat 25 patients
with EBP on the indication of treatment-refractory low
CSF pressure headache. During the follow-up process
seven patients were excluded due to incomplete pre-treat-
ment data, one patient did not ﬁll out post-treatment
headache diary due to ongoing serious illness, one patient
withdrew consent and two patients failed to return post-
treatment headache diaries.
After the follow-up period our study consisted of 14
patients; 2 women and 12 men, aged 33–71 years of age
(mean 52.86). All were treated and observed in the period
2005–2010. All received EBP 177–6,570 days (mean
1,779.29 days) after debut of headache. Follow-up period
was 415–1,759 days (mean 1,258.4 days). Further patient
characteristics are displayed in Table 1.
Despite a number of eliciting causes all patients had
signiﬁcant overlap in symptoms and orthostatic headache
as their core symptom. Nine patients presented with
symptoms of spontaneous intracranial hypotension (SIH),
hereof two patients with a history of tension type headache
and medication overuse headache, and another two patients
reported Valsalva maneuver (sneeze, labor) as eliciting
cause. Two patients reported physical trauma as the elic-
iting cause. The traumas would be categorized as moderate.
One patient was struck by a falling bookcase, resulting in
laceration to the forehead and unconsciousness. The other
trauma was caused by a falling loading ramp on a lorry also
resulting in laceration to the forehead and unconsciousness.
Three patients reported the eliciting cause as iatrogenic
(lumbar puncture or post-operative).
All patients reported a signiﬁcant orthostatic component
as an initial part of their headache. Other symptoms
included fatigue, tinnitus, photophobia, phonophobia, neck
stiffness and concentration problems.
As our primary effect parameter total headache burden
was deﬁned as AUC (mean daily intensity 9 summated
daily duration) and a statistically signiﬁcant reduction was
identiﬁed in AUC [pre-AUC 4,139.1 (±419.8 SEM) vs.
post-EBP AUC 2,997.2 (±582.7 SEM); paired t test
p = 0.015 (CI 265.7; 2,018.1)] (see Fig. 1).
As secondary effect parameters we identiﬁed intensity
(mean daily VAS score) and found a statistically signiﬁcant
reduction [pre-EBP intensity 8.1(±0.4 SEM) vs. post-EBP
intensity 6.2 (±0.6 SEM)]. This represents a reduction of
22% in intensity on VAS 0-10 scale (see Fig. 2).
We found no statistically signiﬁcant reduction in fre-
quency, deﬁned as days with headache (Wilcoxon signed
rank test, p = 0.313). Furthermore, a trend, but not statis-
tically signiﬁcant, a reduction in duration (deﬁned as total
hours of headache per month) was noted [pre-EBP duration
507.9 (±39.4 SEM) vs. post-EBP 421.6 (±71.7 SEM);
paired t test: p = 0.11 (CI -194.9; 22.2)] (see Fig. 3).
Table 1 Patient characteristics (N = 14)
Patient Gender Age
(years)
Eliciting cause/EBP indication ml blood
injected (1st/2nd)
Time in days from
debut to EBP
Follow-up period in
days after last EBP
M1 Male 62 SIH 16 300 1,639
M2 Male 57 SIH 25 180 1,350
F1 Female 63 Iatrogenic (lbp) 20 387 1,890
M3 Male 59 Iatrogenic (post op.) 25/25 3,600 1,677
M4 Male 47 SIH (sneeze) 25/25 1,215 1,759
M5 Male 35 SIH 35 5,110 529
M6 Male 37 Iatrogenic (lbp) 23 438 798
M7 Male 56 Posttraumatic (moderate) 23 6,570 1,738
M8 Male 62 SIH 30/30 730 615
M9 Male 57 SIH 15 1,278 1,336
M10 Male 56 SIH 25/25 180 1,209
M11 Male 71 SIH 17/25 4,015 1,746
M12 Male 45 Posttraumatic (moderate) 30 730 976
F2 Female 33 SIH (labor) 22/12 177 415
Total (N = 14) 12 M/2F 52.9 years 1,779.3 1,258.4
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days 10.0 (Q 0;24) vs. post-EBP days 26.5 days (Q 1;30);
Wilcoxon signed rank test: p = 0.049] was found.
Discussion
We intended to evaluate the treatment efﬁcacy of epidural
blood patch in long-lasting treatment-refractory low CSF
pressure headache. In total, 25 patients were reviewed but
due to losses in the follow-up period we ended up including
14 patients.
In our primary effect parameter, AUC, we found a sig-
niﬁcant reduction with more than 25% and this is consid-
ered to be clinically relevant. Likewise a signiﬁcant and
relevant reduction in intensity at -22% was identiﬁed.
As expected, although statistically not signiﬁcant, a
trend towards reduction in duration was seen, whereas the
headache frequency was unchanged. It can be theorized
that lack of power is the reason for behind this. The
increase in days with use of medication was expected due
to a low number of patients with medication overuse and to
the initiation of optimized treatment strategies in a subset
of patients.
The treatment of low CSF pressure headache has never
been evaluated by randomized clinical trials [3], but sev-
eral series have now documented positive results for EBP
in treating SIH [6–10]. These series report a success rate of
36–90% of complete recovery after one EBP increasing
with the numbers of EBPs. Our series does not quite sup-
port these results. Our patient population differed from
other series in very long headache history, male prepon-
derance and higher age. Although noticeable, neither age-
speciﬁc nor gender-speciﬁc treatment response has ever
been documented. Injected volume was very similar among
studies.
We treated all our patients with lumbar EBP and placed
them in a supine position for 24 h to ensure sufﬁcient
spread. Ferrante [5], Horikushi [6] and Berroir [7], etc. [8,
9] primarily performed lumbar EBPs but used different
post-EBP treatment regimens. Thus, neither age, gender,
site-speciﬁc EBP, nor post-EBP regimen seems to explain
the differences found between this series and earlier pub-
lished results.
A marked difference in this series compared to other
publications is the timing of EBP treatment. In this study a
mean of 1,779.29 days (177–6,570) passed from symptom
onset to EBP treatment in our center. Other series report a
mean of 20–62 days [5, 7–9], Chung et al. [10] performed
EBP treatment after 5–7 days of supportive treatment but
time from symptom onset is unclear. This delay in treat-
ment in our patients was due to further diagnostic workup
and limitations in acute admissions availability. Also these
long lasting patients may be more subtle and differently
affected than the acutely and severely affected patients.
Therefore, increased awareness and a detailed history of
onset of headache is of major importance for the diagnosis,
and some low CSF pressure headache patients may in fact
be overlooked because of their atypical presentation. Sen-
chakova et al. suggested that the EBP procedure was more
effective the more rapidly it was performed after symptom
onset, and that persisting symptoms resulted in slower and
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123incomplete recovery. This suggests a chroniﬁcation of pain
or dysregulation of the intracranial blood volume [8].
Additionally, it is well known that the posture-related
component becomes less prominent over time [9] and
chronic disease involves a signiﬁcant degree of central
sensitization and stigmatization. This could be part of the
explanation behind the difference between this and other
series [7–10]. Worth mentioning is that Ferrante et al. and
Berroir et al. only treated patients with purely orthostatic
headache (40/42 and 30/30), and Chung et al. treated
patients markedly younger and with a shorter delay than
the patients in this study. Our patients had more mixed
symptoms probably again reﬂecting a longer diagnostic
delay contributing to the differences in results.
This study contains some apparent weaknesses. It is
unblinded, retrospective and contains relatively few
patients. The ever present lack of control for spontaneous
recovery also applies to this study, but since the Danish
Headache Center is a tertiary center, all the patients have
received conservative treatment elsewhere, including a
watchful wait. Patient compliance in returning post-treat-
ment headache diaries proved to be a considerable chal-
lenge. Also the level of detail (or lack of) lead to contact to
the treated patients to clarify headache diary entries.
The headache diary, in turn, can also be considered a
strength in addition to a systematic prospective approach
since it allows us to monitor patients more precisely on
several parameters. In turn this allows us to deﬁne more
effect parameters than seen in other studies. Furthermore,
as this is a ‘‘before-and-after’’ study, it contributes to
considerable clinical and statistical validity.
As conclusion, in this pilot study of very long lasting
low CSF pressure headache we found a signiﬁcant reduc-
tion in AUC, a clinically signiﬁcant reduction in intensity
but also a signiﬁcant increase in days with use of medi-
cation after being treated with EBP. Additionally, we
recorded a trend towards a reduction of headache duration
but the very long lasting diagnostic delay may have com-
promised the outcome. Increased awareness and early
diagnosis of low CSF pressure headache is hereby
emphasized and a controlled larger randomized study is
needed to conﬁrm the results. However, the present results
allow us to conclude that EBP in treatment-refractory low
CSF pressure headache can be considered as a treatment
option.
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